WC
GILD icon

Waterloo Capital’s Gilead Sciences GILD Stock Holding History

Waterloo Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$474K Sell
3,755
-68
-2% -$8.96K 0.03% 361
2026
Q1 		$533K Sell
3,823
-1,183
-24% -$166K 0.04% 292
2025
Q4 		$614K Buy
5,006
+1,487
+42% +$181K 0.04% 267
2025
Q3 		$391K Buy
3,519
+345
+11% +$39.2K 0.03% 324
2025
Q2 		$352K Buy
3,174
+793
+33% +$84.4K 0.03% 328
2025
Q1 		$267K Buy
+2,381
New +$246K 0.02% 338

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Waterloo Capital's GILD Position: Q2 2026 in Review

Waterloo Capital reduced its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, selling an estimated $8.96K and leaving 3,755 shares worth $474K. The position accounts for 0.03% of the portfolio, ranked #361.

Waterloo Capital first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $614K in Q4 2025. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Waterloo Capital held 3,755 shares of Gilead Sciences worth $474K as of Q2 2026.
  • Waterloo Capital sold 68 Gilead Sciences shares in Q2 2026, an estimated $8.96K.
  • Gilead Sciences made up 0.03% of Waterloo Capital's portfolio in Q2 2026, its #361 holding.
  • Waterloo Capital first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Waterloo Capital's Gilead Sciences position peaked at $614K in Q4 2025.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.